SpaceX's initial public offering is reportedly drawing significant investor attention. This has raised concerns about a potential liquidity shortage affecting both equities and cryptocurrency markets. Meanwhile, unrelated news suggests that pharmaceutical company Eli Lilly has made progress with its Retatrutide trials, but its impact on the market is uncertain.